Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06574061
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
Evaluation of the Benefits of Sublingual AIT PRACTIS
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation in Routine Practice of the Benefits of Sublingual Allergen Immunotherapy in Allergic Patients According to Different Modalities of Use
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRACTIS
Brief Summary:
The objective of the study was to evaluate in routine practice the benefits of sublingual allergen immunotherapy SLIT for allergic patients with allergic rhinitis AR with or without asthma according to various methods of use treatment regimen formulation type dose duration initiation and type of allergen grass pollen tree pollen herbaceous pollen house dust mites animal dander moulds and poly-reactive types
Detailed Description:
The treatment considered was any SLIT tablet or liquid forms accepted by the patient and the parents in the case of minor patients The treatment was taken as prescribed by the observing physician
The expected benefits for patients after approximately 6 and 12 months after initiation of SLIT included
Decreased intensity of symptoms
Decreased discomfort
Decreased consumption of symptomatic treatments or associated treatments especially in asthmatic patients
Improved quality of life
Reduced absenteeism from school or work
Beneficial impact on leisure activities
The expected benefits for patients after approximately 6 and 12 months after initiation of SLIT included
Decreased intensity of symptoms
Decreased discomfort
Decreased consumption of symptomatic treatments or associated treatments especially in asthmatic patients
Improved quality of life
Reduced absenteeism from school or work
Beneficial impact on leisure activities
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None